SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is currently trending as retail investors speculate on potential inclusion in the Russell 1000 index, fueling intense debate regarding the stock's future liquidity and its ongoing battle between bullish long-term sentiment and heavy short interest. While the community remains divided over the outcome of index rebalancing, investors are primarily focused on upcoming regulatory milestones and the long-term commercialization potential of the company's immunotherapy platform.

ON Semiconductor Corp. engages in the provision of intelligent power and sensing solutions with a primary focus on automotive and industrial markets. It operates through the following segments: Power Solutions Group (PSG), Analog and Mixed-Signal Group (AMG), and Intelligent Sensing Group (ISG). The PSG segment offers discrete, module, and integrated semiconductor products that perform multiple application functions, including power switching, signal conditioning, and circuit protection. The AMG segment designs and develops analog, mixed-signal, power management integrated circuits, sensor interface devices, power conversion, signal chain, and voltage regulation devices. The ISG focuses on the design and development of complementary metal oxide semiconductor image sensors, image signal processors, single photon detectors, including silicon photomultipliers, single photon avalanche diode arrays, and short-wavelength infrared products, as well as actuator drivers for autofocus and image stabilization. The company was founded on July 4, 1999 and is headquartered in Scottsdale, AZ.

ON Semiconductor Corp.

ON Semiconductor is facing significant downward pressure following the announcement of an all-stock acquisition of Synaptics, which has triggered immediate market concern regarding dilution and the strategic focus of the deal. While some community members view the dip as an oversold opportunity driven by structural optics rather than a fundamental collapse, others are actively debating the timing and valuation, leading to high-volume volatility as arbitrage traders position themselves.

FuboTV, Inc. is a consumer-first live TV streaming company with the mission of delivering premium sports, news and entertainment programming that offers greater choice, flexibility and value. The company was founded by David Gandler, Alberto Horihuela Suarez, and Sung Ho Choi on February 20, 2009 and is headquartered in New York, NY.

fuboTV Inc - Ordinary Shares - Class A

fuboTV Inc

FuboTV is experiencing heightened volatility and community interest driven by a new distribution deal with NBCUniversal and the start of the FIFA World Cup. While bulls are highlighting the potential for a short squeeze and long-term value within the Disney ecosystem, many retail investors remain skeptical, focusing heavily on concerns over management's history, recent insider selling, and significant past share dilution.

Lucid Group, Inc. manufactures electric vehicles. It designs, develops, and builds energy storage systems for electric vehicles and supplies automakers with the battery pack system needed to power hybrid, plug-in, and electric vehicles. The company was founded in December 2007 and is headquartered in Newark, CA.

Lucid Group Inc

Lucid Group is experiencing heightened volatility following the official announcement of a mid-2027 robotaxi service in Houston in partnership with Uber and Nuro. While the community remains deeply divided, with many expressing concern over management turnover and cash flow, others are focused on potential short-squeeze activity as traders closely monitor high short-interest levels and borrow rates.

Icahn Enterprises LP is a holding company. It operates through the following segments: Investment, Automotive, Energy, Food Packaging, Real Estate, Home Fashion, Pharma, and Holding Company. The Investment segment consists of various private investment funds. The Automotive segment holds ownership in Icahn Automotive Group, LLC. The Energy segment refers to petroleum refining and marketing businesses. The Food Packaging segment involves the production and sale of cellulosic, fibrous, and plastic casings for the processed meat and poultry industry. The Real Estate segment offers rental real estate, property development, and resort activities. The Home Fashion segment deals with manufacturing, sourcing, marketing, distributing, and selling home fashion consumer products. The Pharma segments operate through Vivus, Inc., a specialized pharmaceutical company. The Holding Company segment manages acquisition and investment in operating businesses. The company was founded on February 17, 1987 and is headquartered in Sunny Isles Beach, FL.

Icahn Enterprises L P - Unit

Icahn Enterprises, L.P.

Icahn Enterprises is seeing renewed investor interest driven by a strategic pivot toward energy and potential upside from subsidiary holdings, despite ongoing concerns regarding dilution and the sustainability of its quarterly distributions. The community is closely watching upcoming earnings and operational developments, with many retail holders maintaining long-term positions in anticipation of a potential reversal in share price.

POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada.

POET Technologies Inc

POET Technologies is seeing intense community focus ahead of its upcoming AGM and U.S. redomicile vote, with active debates centered on whether management's conservative guidance masks significant upcoming customer announcements. While shareholders are navigating volatility fueled by heavy short-interest and sector-wide sentiment shifts, the community is closely watching for proof of manufacturing scale and potential new orders to drive a rebound.

AbCellera Biologics, Inc. engages in the development of therapeutic antibodies. It offers antibody discovery platform that searches, decodes and analyzes natural immune systems to find antibodies that can be developed to prevent and treat disease. The company was founded by Carl Lars G. Hensen, Kathleen Lisaingo, Kevin Heyries, Véronique Lecault and Daniel Da Costa on November 8, 2012 and is headquartered in Vancouver, Canada.

AbCellera Biologics Inc

AbCellera is experiencing significant volatility and intense trading volume as community members debate whether recent clinical data and strategic pipeline shifts represent a generational value opportunity or continued underperformance. Long-term investors are keenly focused on upcoming Q3 readout catalysts, while active discussions center on the company's shift toward internal drug development and the potential for a massive valuation re-rating.

Sable Offshore Corp. engages in offshore oil and gas field operations. It focuses on developing the prolific Santa Ynez Unit in federal waters offshore California. The company was founded by James C. Flores on October 16, 2020 and is headquartered in Houston, TX.

Sable Offshore Corp.

Sable Offshore is capturing significant investor attention as operations ramp up and the company secures key off-take agreements, fueling debates over the stock's potential for a major short squeeze. While community members are divided between concerns over ongoing legal challenges with California regulators and optimism regarding strong federal support and high-margin production, the stock remains a focal point for those betting on the company's ability to navigate these institutional and political hurdles.

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980, and is headquartered in Cambridge, MA.

Sarepta Therapeutics Inc

Sarepta Therapeutics is trending as investors speculate about a potential buyout amid strong volume, while the community remains divided over management's leadership and the stock's significant undervaluation relative to its revenue. Discussions are heavily focused on the company's long-term potential in rare disease genetic therapies versus its ongoing struggle to break out of a persistent downtrend.

Onyx is an infrastructure for a multi-asset, scalable, and cryptographically secure ledger. Onyx functions as a blockchain-based technology that enhances financial ecosystems by enabling a more efficient and interconnected economy, with a mission to develop cryptographic ledgers that optimize security, scalability, and usability. XCN is native to the Onyx XCN Ledger Blockchain as well as the Onyx Goliath Blockchain. XCN is also used as an ERC-20 token for Staking and Governance.

Onyxcoin

Onyxcoin is seeing increased community activity fueled by anticipation for the upcoming Goliath mainnet launch and discussions around its potential role in institutional financial infrastructure. While some investors are bullish on the network upgrade and long-term utility, others remain skeptical, warning of historical price volatility and questioning the transparency of the project's development team.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

ATGN's Q2 Earnings Flat Y/Y, Sees Decline in Cloud Revenue

Altigen posts fiscal Q2 EPS of 1 cent, with a shift toward AI-powered CXaaS solutions but faces lower cloud revenue. 

The Zacks Analyst Blog Highlights Meta Platforms, Netflix, Pfizer, SIFCO Industries and Altigen Communications

Meta's AI push lifts engagement, Netflix eyes revenue doubling by 2030, and Pfizer leans on new launches to offset looming patent cliffs.

Top Research Reports for Meta, Netflix & Pfizer

Meta Platforms, Netflix and Pfizer lead fresh research as AI bets, bold 2030 goals and patent cliffs shape their outlooks.

ATGN's Earnings Break Even in Q1, Down Y/Y Due to High Customer Churn

Altigen's fiscal Q1 results face revenue decline from legacy platform transition, but strong margins, cost control and upcoming AI launches signal potential growth in the second half of FY2026.

Zacks Initiates Coverage of Altigen With Neutral Recommendation

Uncover why Zacks initiated coverage on ATGN with a "Neutral" rating, being the first on Wall Street to initiate coverage on the stock. See how cloud partnerships, Microsoft-focused solutions and a return to profitability balance against customer concentration and competitive pressure.

Altigen Communications, Inc. engages in the provision of Microsoft cloud solutions. It operates through North America and Rest of the World geographical segments. The North America segment consists of United States, Canada, Mexico, Central America, and the Caribbean. The Rest of the World segment focuses on Europe. The company was founded by Gilbert Hu in May 1994 and is headquartered in Milpitas, CA.

Altigen Communications Inc

Neutral Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Feed

News

Sentiment

Earnings

Fundamentals

Info

ATGNAltiGen Communications Inc.

Fundamentals

Latest ATGN News